Popular search terms:
Search Results Label
17 results found-
Seqirus announces next major advancement in cell-based influenza
In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.
https://www.seqirus.ca/...based-influenza-vaccine-technology -
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.ca/ -
US Media Release Template Q3 2013
Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally, with extensive research and production
https://www.seqirus.ca/-/media/seqirus-us/news/franchise-shipment-press-release--71116final-530-pm.pdf -
New Clinical Data Reinforces the Ability of MF59 Adjuvanted Seasonal
Seqirus Presents New Clinical Data that Reinforce the Ability of MF59® Adjuvanted Seasonal and Pandemic Influenza Vaccines to Increase Immune Response
https://www.seqirus.ca/...al-and-pandemic-influenza-vaccines -
Seqirus is first-to-market with shipment of seasonal influenza
Seqirus is first-to-market with shipment of seasonal influenza vaccines to the US for the 2016-2017 season
https://www.seqirus.ca/...enza-vaccines-for-2016-2017-season -
Seqirus Begins Shipping 2017-2018 Influenza Vaccines to the U
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.seqirus.ca/...pping-2017-2018-influenza-vaccines -
Seqirus Begins Shipping 2018 2019 Influenza Vaccines to the US
Seqirus Begins Shipping 2018-2019 Influenza Vaccines to the U.S. Market
https://www.seqirus.ca/...nfluenza-vaccines-to-the-us-market -
Seqirus | About Us
Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.seqirus.ca/our-company -
New Scientific Data Comparing Circulating Influenza B Viruses
Seqirus Presents New Scientific Data Comparing Circulating Influenza B Viruses With Both Cell-Based and Egg-Based Influenza B Reference Viruses
https://www.seqirus.ca/...ng-circulating-influenza-b-viruses -
Seqirus secures FDA approval for next generation cell based influenza
Seqirus secures FDA approval for next generation cell-based influenza vaccine manufacturing process
https://www.seqirus.ca/...enza-vaccine-manufacturing-process